SCHEMBL24825664

SCHEMBL24825664

c1ccc(-c2ccccc2N(c2ccc(-c3cc4ccccc4c4ccccc34)cc2)c2ccc3c(c2)oc2c4ccccc4ccc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 11/20 0.37
▸ CYP1B1 Q16678 11/20 0.37
▸ CYP1A2 P05177 10/20 0.37
▸ ABCG2 Q9UNQ0 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ PRKDC P78527 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ PDE5A O76074 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ ABCB1 P08183 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CYP2B6 P20813 1/20 0.37
▸ TACR2 P21452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26021077 0.99 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL24888624 0.95 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL26061178 0.95 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL26020271 0.94 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL26020214 0.94 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL26021084 0.93 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL24889280 0.93 KDM4E (0.36) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL26021080 0.93 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL24825962 0.92 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4
SCHEMBL26046518 0.92 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ABCG2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
US-20220416174-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, NR1D1 CYP1A1 8/4885CYP1B1 43/4885CYP1A2 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback